Subscribe

DCI Blog

All
All

Duke Cancer Institute (DCI) Blog provides updates, organizational announcements, the latest in funding opportunities and information on upcoming conferences and symposiums. This blog also highlights inspiring patient stories and the accomplishments and achievements of DCI faculty and staff. Subscribers are invited to submit story ideas and other news of interest. Email submissions and feedback to Karen E. Butler, Director of Communications, Duke Cancer Institute.

Previs Awarded Scholarship for Ovarian Cancer Research

Rebecca Previs, MD , has been selected as a recipient of a 2019 American Association of Obstetricians and Gynecologists Foundation (AAOGF) and GOG Foundation Scholarship Award. The $120,000 scholarship will support her research-training program and project “Immune Modulation of CaMKK2 in the...

Shake Your Teal Feathers To Host Garage Sale

Team Shake Your Teal Feathers, whose members work at Duke Women’s Cancer Care Raleigh, is raising funds to support the 2018 Gail Parkins Memorial Ovarian Cancer 5K and Walk. To bolster their totals, the team will host a Garage Sale on Saturday, Sept. 8. The Gail Parkins Memorial Ovarian 5K takes...

Tim McGraw Sends Video Message To Cancer Patient

Kathy Wolf was hospitalized at Duke in late June due to a complication from end-stage ovarian cancer. The Youngsville resident kept asking whether she’d be able to leave the hospital in time to go see one of her favorite singers, country music star Tim McGraw, at his concert in Raleigh on Friday,...

Ovarian Cancer Screening: Cost Effective?

A group of Duke Cancer Institute gynecologic oncology researchers has published a new paper this month with their projections on the cost-effectiveness of ovarian cancer screening in the U.S., based on their analysis of published results of the UK Collaborative Trial of Ovarian Cancer Screening (...

A Value-Based Approach To The Use Of PARP Inhibitors in Ovarian Cancer

A group of Duke Cancer Institute gynecologic oncologists, led by Andrew Berchuck, MD, are advising, in a perspectives article in the Journal of Clinical Oncology , that an evidence- and biomarker guided strategy-offers the best value-based approach to the use of oral PARP inhibitor drugs as...

Ovarian Cancer Walk Raises $250K for DCI Research

The 15th annual Gail Parkins Memorial Ovarian Cancer Walk and 5K Run, held on Saturday, Sept. 16, in Raleigh, raised more than $250,000 this year for ovarian cancer research at Duke Cancer Institute. Andrew Berchuck, MD, who directs the Division of Gynecologic Oncology and Duke Cancer Institute’s...

Risk-Reducing Surgery Questioned For Some BRCA Mutation Carriers

Mutations in the BRCA gene correspond to a higher lifetime risk of developing breast and ovarian cancers, and many women who carry these mutations consider undergoing mastectomy or removal of the ovaries and fallopian tubes as preventive measures. But for the subset of women with BRCA mutations who...

Lace Up For The 2017 Ovarian Cancer Walk/Run

The 2017 Gail Parkins Memorial Ovarian Cancer Walk and 5K Run will take place Saturday, Sept. 16, at Sanderson High School, located at 5500 Dixon Drive in Raleigh, North Carolina. The event, which raises both awareness and funds for ovarian cancer research at Duke, features a 5K run and a 2-mile...

Genetic Study Identifies 12 New Variants For Ovarian Cancer

A genetic examination of the DNA of almost 100,00 people, including 17,000 patients with the most common type of ovarian cancer, has identified 12 new genetic variants that increase risk of developing the disease and confirmed the association of 18 of the previously published variants. Published...

Nationwide Ovarian Cancer Clinical Trial Shows Promise

When IBM IT architect Laura Elzie, 60, was first diagnosed with ovarian cancer three years ago by her long-time primary care physician she was momentarily stunned when she heard, “Some of us never know how we are going to leave this world, but at least you know.” For months she’d been told her pain...

Ovarian Cancer Survivors and Families Help Advance Research

It’s been called the silent killer because it spreads fairly quietly, before causing painful symptoms. By the time many women are diagnosed with ovarian cancer, its already advanced through the abdominal cavity. This is what happened to Gail Parkins, who, at the age of 54, was eventually diagnosed...

Women with BRCA1 Gene Mutation at Higher Risk of Deadly Uterine Cancer

Women who carry the BRCA1 gene mutation that dramatically increases their risk of breast and ovarian cancers are also at higher risk for a lethal form of uterine cancer, according to a study led by a Duke Cancer Institute researcher. This newly defined risk -- the first to show a conclusive link...

Pages